Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemotherapeutic neurotoxicity].

C Lebrun1, M Frenay

  • 1Service de Neurologie, CHU de Nice.

Revue Neurologique
|September 19, 2003
PubMed
Summary
This summary is machine-generated.

Antineoplastic therapy can cause neurotoxicity, impacting patient quality of life and treatment options. Early detection is crucial as neurological complications are often irreversible when diagnosed late.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trial.

Revue neurologique·2021
Same author

Atypical myelitis in patients with multiple sclerosis: Characterization and comparison with typical multiple sclerosis and neuromyelitis optica spectrum disorders.

Multiple sclerosis (Houndmills, Basingstoke, England)·2020
Same author

Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society.

Revue neurologique·2019
Same author

Digestive side-effects with teriflunomide: Thoughts on lactose.

Revue neurologique·2018
Same author

Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients.

Journal of neurology·2018
Same author

Demyelinating diseases.

Revue neurologique·2018

Area of Science:

  • Neuroscience
  • Oncology
  • Pharmacology

Context:

  • Antineoplastic therapies, while crucial for treating cancer, frequently lead to nervous system damage.
  • Neurotoxicity is a recognized complication, influenced by treatment routes and dosages.
  • The rise in multi-modality, dose-intensive, and experimental cancer treatments correlates with increasing neurological toxicity.

Purpose:

  • To highlight the significant incidence and impact of neurotoxicity associated with cancer treatments.
  • To emphasize the critical need for ongoing clinical surveillance for neurological complications.
  • To underscore the limited reversibility of late-diagnosed neurological damage.

Summary:

  • Damage to the nervous system is a common complication of antineoplastic therapy.

Related Experiment Videos

  • Neurotoxicity arises from synergistic or additive effects of cytotoxic treatments, with exposure linked to routes and doses.
  • Neurological toxicity can limit treatment aggressiveness and negatively affect patient quality of life.

    • Impact:

    • Neurological toxicity is a significant factor affecting patient quality of life and treatment adherence.
    • Delayed diagnosis of neurological complications often results in irreversible damage.
    • The development and evaluation of neuroprotective agents are ongoing areas of research.